Eva de Lago

12PUBLICATIONS
31CO-AUTHORS
Biologically active moleculesCharacterisation of biological macromoleculesTissue engineeringPredictive and prognostic markersMedical biochemistry - amino acids and metabolites
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 11, 2025
Relevance of a peripheral site of action outside the brain-blood barrier for the beneficial effects of CB2 receptor activation in experimental ALS in male mice.

Marta Gómez-Almería, Claudia Gonzalo-Consuegra, Carmen Rodríguez-Cueto

|Mar 11, 2025
Development of Novel Neuroprotective Agents Targeting GPCR Using in Vitro Assays.

María Gómez-Cañas, Carmen Rodríguez-Cueto, Javier Fernández-Ruiz

|Sep 28, 2024
Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia.

Ignacio Silva-Llanes, Raquel Martín-Baquero, Alicia Berrojo-Armisen

|May 06, 2023
Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice.

Irene Santos-García, Carmen Rodríguez-Cueto, Patricia Villegas

|Oct 27, 2022
Discovery of Mitophagy Inhibitors with Therapeutic Potential in Different Familial Amyotrophic Lateral Sclerosis Mutations.

Ines Maestro, Laura R de la Ballina, Gracia Porras

|Sep 23, 2022
New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.

Isabel Lastres-Becker, Eva de Lago, Ana Martínez

Pageof 2